Our results show that TCA metabolite signaling pathways are perturbed in TREM2 LoF variant iPS‐Mg contributing to the observed metabolic and functional deficits displayed by those cells (Fig. 7), providing insights into the relationship between dysfunctional metabolism and TREM2 with implications for AD pathogenesis and treatments. Here, TREM2 is linked to Alzheimer disease.